Advertisement

Updated October 30th, 2021 at 08:34 IST

US FDA clears Pfizer's COVID vaccine for kids aged 5 to 11; CDC to discuss authorisation

The United States Food and Drug Administration (FDA) on Friday, 29 October authorised the use of Pfizer-BioNTech’s COVID-19 vaccine for children ages 5 to 11.

Reported by: Aanchal Nigam
FDA
IMAGE: Unsplash | Image:self
Advertisement

The United States Food and Drug Administration (FDA) on Friday, 29 October authorised the use of Pfizer-BioNTech’s COVID-19 vaccine for children ages 5 to 11. To make the shots finally available to 28 million kids in the country, FDA’s nod should be followed by the US Centres for Disease Control and Prevention (CDC) to sign off. The CDC has scheduled an advisory committee meeting to review the pediatric doses next week.

As per CNBC, the advisory panel is expected to swiftly clear the doses for public distribution immediately after the CDC review meeting. The FDA said in a statement that the decision was based on the food and drug administration's “thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favour of making the vaccine available to children in this age group.”

The FDA further noted the immune responses of children between the age of 5 and 11 were compared with those of individuals 16 through 25 years of age. The Pfizer-BioNTech shots have shown 90.7% efficacy in preventing COVID-19 in children aged 5-11. The Food and Drug Administration said that it studied the vaccine safety in approximately 3,100 children among the same age group of 5 to 11 “and no serious side effects have been detected in the ongoing study.”

 

‘I know parents have been waiting’

Acting FDA Commissioner Janet Woodcock said in a statement, “As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy. Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”

Presently, the full-strength Pfizer-BioNTech shots are recommended for everyone at the age of 12 and above. But, both parents and paediatricians are reportedly seeking protection for younger children. FDA’s advisory panel endorsing Pfizer shots for children aged 5-11 came after Moderna on Monday stated that a “robust neutralising antibody response” is generated by its COVID-19 vaccine in children between the ages 6 and 11. Following the phase 2-3 trials, the company said that it would soon submit the data to global regulators.

(IMAGE: Unsplash)
 

Advertisement

Published October 30th, 2021 at 08:34 IST

Your Voice. Now Direct.

Send us your views, we’ll publish them. This section is moderated.

Advertisement
Advertisement

Trending Quicks

Airbrush Brow Trend: Know Its Benefits, Procedure, And More
a few seconds ago
Kerala Nirmal Lottery Sambad Friday Result
a few seconds ago
HD Kumaraswamy
a few seconds ago
Congress Press Conference
a minute ago
 Development is BJP's Main Agenda Says Kangana Ranaut As She Launches Campaign In Mandi
3 minutes ago
Dog walking tips
3 minutes ago
Vijay Varma
5 minutes ago
Virat Kohli and Gautam Gambhir
7 minutes ago
Bharat Rashtra Samithi (BRS) Rajya Sabha MP Keshava Rao is set to join the Congress party.
11 minutes ago
Pak PM Shehbaz Sharif Meets Country's Youngest Vlogger
13 minutes ago
Byju's leadership dispute
13 minutes ago
Advertisement
Advertisement
Advertisement
Whatsapp logo